| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biochemistry and Molecular Biology (K.R.T., T.E.H., K.M.W., J.A.R., M.S., T.C.S.), Department of Internal Medicine (B.L.R.), Division of Endocrinology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905
Address all correspondence and requests for reprints to: Thomas C. Spelsberg, Department of Biochemistry and Molecular Biology, Division of Endocrinology, Mayo Clinic and Mayo Foundation, Guggenheim Building, Room 1601A, Rochester, Minnesota 55905. E-mail: Spelsberg.Thomas{at}mayo.edu
This laboratory reported the identification and characterization of a unique three zinc finger, transcription factor-like, transforming growth factor-ß inducible early gene (TIEG) (see Ref. 35). TIEG expression has been shown to be tissue- and cell type specific, enhanced by specific growth factors, and to decrease with advancing stages of breast cancer. Recent studies involving TIEG overexpression in pancreatic carcinoma cells indicate that TIEG expression inhibits DNA synthesis, similar to a tumor suppressor-like gene, and plays a role in apoptosis (see Ref. 37). This paper describes the rapid, but transient, induction of TIEG steady-state messenger RNA (mRNA) levels by 17ß-estradiol (E2) in estrogen receptor (ER)-positive, human fetal osteoblastic (hFOB/ER) cells. This rapid induction is shown to be ER- and steroid dose-dependent but protein synthesis independent. An antagonism between E2 and PTH, which occurs in skeletal metabolism, is shown to concur rapidly with TIEG mRNA expression. Scanning confocal microscopy (using polarized, laser-based immunofluorescence) shows that TIEG protein is localized in the nucleus of hFOB/ER cells, with the levels rapidly increasing after E2 treatment. The rapid E2-induced increase in TIEG expression is followed by an E2-induced inhibition of DNA synthesis in the hFOB/ER cells. Antiestrogens block not only the induction of TIEG mRNA levels but also the inhibition of cell proliferation. Lastly, hFOB cells, stably transfected with a TIEG expression vector, display markedly reduced DNA synthesis/cell proliferation, compared with nontransfected cells. These results support the finding that TIEG is an early responding regulatory gene for E2 in human osteoblast cells that inhibits DNA synthesis. It is speculated that TIEG may play a role in the signaling pathway for E2 in inhibiting cell proliferation.
This article has been cited by other articles:
![]() |
A. P. W. Funnell, C. A. Maloney, L. J. Thompson, J. Keys, M. Tallack, A. C. Perkins, and M. Crossley Erythroid Kruppel-Like Factor Directly Activates the Basic Kruppel-Like Factor Gene in Erythroid Cells Mol. Cell. Biol., April 1, 2007; 27(7): 2777 - 2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Subramaniam, G. Gorny, S. A. Johnsen, D. G. Monroe, G. L. Evans, D. G. Fraser, D. J. Rickard, K. Rasmussen, J. M. A. van Deursen, R. T. Turner, et al. TIEG1 Null Mouse-Derived Osteoblasts Are Defective in Mineralization and in Support of Osteoclast Differentiation In Vitro Mol. Cell. Biol., February 1, 2005; 25(3): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Tomlinson, J. C. Grindley, and A. A. Thomson Regulation of Fgf10 Gene Expression in the Prostate: Identification of Transforming Growth Factor-{beta}1 and Promoter Elements Endocrinology, April 1, 2004; 145(4): 1988 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Hinnebusch, A. Siddique, J. W. Henderson, M. S. Malo, W. Zhang, C. P. Athaide, M. A. Abedrapo, X. Chen, V. W. Yang, and R. A. Hodin Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppel-like factor Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G23 - G30. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cook, B. Gebelein, M. Belal, K. Mesa, and R. Urrutia Three Conserved Transcriptional Repressor Domains Are a Defining Feature of the TIEG Subfamily of Sp1-like Zinc Finger Proteins J. Biol. Chem., October 8, 1999; 274(41): 29500 - 29504. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Spelsberg, M. Subramaniam, B. L. Riggs, and S. Khosla The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton Mol. Endocrinol., June 1, 1999; 13(6): 819 - 828. [Full Text] |
||||
![]() |
T. Cook, B. Gebelein, K. Mesa, A. Mladek, and R. Urrutia Molecular Cloning and Characterization of TIEG2 Reveals a New Subfamily of Transforming Growth Factor-beta -inducible Sp1-like Zinc Finger-encoding Genes Involved in the Regulation of Cell Growth J. Biol. Chem., October 2, 1998; 273(40): 25929 - 25936. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Hefferan, G. G. Reinholz, D. J. Rickard, S. A. Johnsen, K. M. Waters, M. Subramaniam, and T. C. Spelsberg Overexpression of a Nuclear Protein, TIEG, Mimics Transforming Growth Factor-beta Action in Human Osteoblast Cells J. Biol. Chem., June 30, 2000; 275(27): 20255 - 20259. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |